Studies on filarial GST as a target for antifilarial drug development—in silico and in vitro inhibition of filarial GST by substituted 1,4-naphthoquinones

被引:0
|
作者
Nisha Mathew
Lakshmy Srinivasan
Twinkle Karunan
Elango Ayyanar
Kalyanasundaram Muthuswamy
机构
[1] Indian Council of Medical Research,Vector Control Research Center
来源
关键词
1,4-naphthoquinone; Antiparasitic; Macrofilaricidal; Lymphatic filariasis; GST inhibition; AutoDock;
D O I
暂无
中图分类号
学科分类号
摘要
Eleven 1,4-naphthoquinone analogues with different amino substitutions at position 3 of the quinone ring earlier reported for macrofilaricidal activity were selected and screened against purified cytosolic GST isolated from the bovine filarial worm Setaria digitata and IC50 values were determined. Of the 11 compounds tested, 8 showed good inhibition against S. digitata GST. The IC50 values of the most effective macrofilaricidal compounds—11 [2-(4-methylpiperazin-1-yl)naphthalene-1,4-dione] and 9 {2-[(1,3-dimethylbutyl)amino]naphthalene -1,4-dione}—were 0.872 and 0.994 mM, respectively. Compounds 9 and 11 were further studied for type of enzyme inhibition and found to exhibit competitive and uncompetitive inhibition kinetics, respectively, with respect to substrate GSH. All 11 compounds were in agreement with Lipinski’s rule of five and passed through the FAFDrugs ADME/tox filter. Molecular docking was carried out using the modeled 3D structure of wbGST PDB ID:1SFM as receptor and substituted naphthoquinones as ligands using AutoDock 4.0. The binding energy of nine compounds varied from −9.15 to −6.58 Kcal mol−1, whereas compounds 8 and 10 did not show any binding to the receptor. Among the compounds studied, compound 7 {2-[3-(diethylamino) propyl]aminonaphthalene-1,4-dione} showed maximum affinity towards wbGST as it exhibited the lowest binding energy, followed by compounds 11 and 9. However compound 7 was not macrofilaricidal while 11 and 9 exhibited macrofilaricidal activity. The results of in silico and in vitro studies with the synthesized 1,4 -naphthoquinone analogues on filarial GST and in vitro macrofilaricidal activity against adult bovine filarial worm S. digitata open up a promising biochemical target for antifilarial drug development.
引用
收藏
页码:2651 / 2657
页数:6
相关论文
共 20 条
  • [11] STUDIES IN THE JUGLONE SERIES .4. THE ADDITION OF ANILINE AND TOLUENE-PARA-THIOL TO 5-SUBSTITUTED 1,4-NAPHTHOQUINONES
    MACLEOD, JW
    THOMSON, RH
    JOURNAL OF ORGANIC CHEMISTRY, 1960, 25 (01): : 36 - 42
  • [12] Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies
    Aly, Ashraf A.
    El-Sheref, Essmat M.
    Bakheet, Momtaz E. M.
    Mourad, Mai A. E.
    Brown, Alan B.
    Braese, Stefan
    Nieger, Martin
    Ibrahim, Mahmoud A. A.
    BIOORGANIC CHEMISTRY, 2018, 81 : 700 - 712
  • [13] Novel O-propyl, S-propyl, and N-propyl substituted 1,4-naphthoquinones and 1,4-anthraquinones as potential fingermark development reagents for porous surfaces
    Berkil Akar, Kiymet
    JOURNAL OF FORENSIC SCIENCES, 2021, 66 (01) : 161 - 171
  • [14] Synthesis and examination of 1,2,4-triazine-sulfonamide hybrids as potential inhibitory drugs: Inhibition effects on AChE and GST enzymes in silico and in vitro conditions
    Rozbicki, Przemyslaw
    Oguz, Ercan
    Wolinska, Ewa
    Turkan, Fikret
    Cetin, Adnan
    Branowska, Danuta
    ARCHIV DER PHARMAZIE, 2024, 357 (09)
  • [15] SYNTHESIS AND PHARMACOLOGICAL STUDIES OF SOME (1,4)-NAPHTHOQUINONO[3,2-C]-1H-PYRAZOLES, 2-SUBSTITUTED AMINO-1,4-NAPHTHOQUINONES, AND RELATED-COMPOUNDS
    TANDON, VK
    VAISH, M
    KHANNA, JM
    ANAND, N
    ARCHIV DER PHARMAZIE, 1990, 323 (07) : 383 - 385
  • [16] Comprehensive approach to in silico identification and in vitro validation of anti-filarial hit molecules targeting the dimer interface of thioredoxin peroxidase 1 in Wuchereria bancrofti: a progress in anti-filariasis drug development
    Sureshan, Muthusamy
    Rajamanikandan, Sundarraj
    Saraboji, Kadhirvel
    MOLECULAR DIVERSITY, 2024, : 1393 - 1413
  • [17] Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies
    Andrade, E. L.
    Bento, A. F.
    Cavalli, J.
    Oliveira, S. K.
    Freitas, C. S.
    Marcon, R.
    Schwanke, R. C.
    Siqueira, J. M.
    Calixto, J. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (11)
  • [18] In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis
    Deb, Pran Kishore
    Al-Shar'i, Nizar A.
    Venugopala, Katharigatta N.
    Pillay, Melendhran
    Borah, Pobitra
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 869 - 884
  • [19] A New Insight into Non-covalent Interactions in 1,4-Disubstituted 1H-1,2,3-Triazole: Synthesis, X-ray structure, DFT calculations, in vitro Lipoxygenase Inhibition (LOX) and in silico Studies
    Ahmed, Muhammad Naeem
    Shabbir, Sadia
    Batool, Bakhtawar
    Mahmood, Tariq
    Rashid, Umer
    Yasin, Khawaja Ansar
    Tahir, Muhammad Nawaz
    Arias Cassara, M. L.
    Gil, Diego M.
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1236
  • [20] Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies
    Kapron, Barbara
    Luszczki, Jarogniew J.
    Plazinska, Anita
    Siwek, Agata
    Karcz, Tadeusz
    Grybos, Anna
    Nowak, Gabriel
    Makuch-Kocka, Anna
    Walczak, Katarzyna
    Langner, Ewa
    Szalast, Karolina
    Marciniak, Sebastian
    Paczkowska, Magdalena
    Cielecka-Piontek, Judyta
    Ciesla, Lukasz M.
    Plech, Tomasz
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 129 : 42 - 57